Beyond Androgen Deprivation Therapy: Next-Generation Hormonal Therapies and Emerging Combination Approaches in Advanced Prostate Cancer
Multiple phase 3 studies have shown that early use of androgen receptor (AR) pathway inhibitors (ARPIs) results in marked improvement in overall survival for men with metastatic androgen pathway modulation-sensitive (APMS) prostate cancer (formerly castration-sensitive prostate cancer). However, resistance to these age...